Lexology January 22, 2024
DLA Piper

On January 5, 2024, FDA authorized Florida’s Section 804 Importation Program (SIP) proposal to allow Florida’s Agency for Health Care Administration (AHCA) to import drugs from Canada for a period of two years. AHCA revised their 2020 proposal to the FDA several times and submitted clarifying communications prior to the agency’s determination. While eight other states have laws that permit drug importation, and six of them are seeking FDA approval, this is the first time that the FDA has approved a state entity to import drugs from another country.[1][2]

For a state to be able to import drugs, there are a number of hurdles it must overcome. Section 804 of the of the Federal Food, Drug, and Cosmetic Act requires...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Biotechnology, FDA, Govt Agencies, Pharma, Pharma / Biotech, States
FDA issues flu vaccine recommendations: 5 respiratory updates
5 Digital Health Areas To Be Impacted By The FDA Layoffs
FDA Approves First Biosimilar to Omalizumab
Trump's Nominees to Run FDA, NIH Get Greenlighted by Senate Committee
FDA Debuts a New Communications and Compliance Tool for Device Data Integrity Concerns

Share This Article